The DOI matches its Crossref record.
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life
Abstract
Nitric oxide (NO), which accounts for the biological properties of endothelium-derived relaxing factor, is generated by NO synthase (NOS). The vascular endothelium contains two types of NOS: one is constitutively expressed (cNOS), and the other is inducible. Endothelium-mediated vasorelaxation is impaired in atherosclerotic vessels. To determine whether tumor necrosis factor (TNF)-alpha, which is commonly found in atherosclerotic lesions, has an effect on NOS message, we measured cNOS mRNA levels in TNF-treated human umbilical vein endothelial cells (HUVECs) by RNA blot analysis with a cNOS cDNA probe. TNF-alpha markedly reduced cNOS mRNA levels in HUVECs in a dose- and time-dependent manner. In response to 3 ng/mL TNF-alpha, cNOS mRNA levels began to decrease at 4 hours and diminished to only 5% of control levels at 24 hours. As little as 0.1 ng/mL TNF-alpha reduced cNOS mRNA levels by 50%. This reduction in cNOS message in response to TNF-alpha depended on protein synthesis as it was blocked by cycloheximide. In nuclear runoff experiments, TNF-alpha did not change the rate of cNOS gene transcription. cNOS mRNA is very stable under basal conditions, with a half-life of 48 hours; however, treatment with TNF-alpha shortened this half-life to 3 hours. TNF-alpha thus appears to decrease cNOS mRNA levels by increasing the rate of mRNA degradation. TNF-induced reductions in cNOS mRNA levels may have an important effect on impaired endothelium-mediated vasorelaxation in atherosclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“was shown to downregulate NOS3 expression and abundance [123, 131-134] by decreasing the stability of NOS3 mRNA [135, 136], effectively shortening its half-life [137].”
From Regulation of obesity and insulin resistance by nitric oxide (2014) · cites this paper as [137]
Citations
Cited by
Sorted by citations
Items 601–700 of 775
Effect of recombinant human erythropoietin on inflammatory status in dialysis patients
Aguilera, A. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh1056 · Cited by 7
“Nitrate (NO3) representing NO, TM and vWF are considered to be markers of endothelial damage [11–13], and are affected by inflammatory molecules [10,16,36,38,39].”
Backgroundten Hacken, N. H. T., Postma, D. S., Drok, G., Smith, M. A., Kraan, J., & Timens, W. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.016003445.x · Cited by 7
Effects of aurantiamide on a rat model of renovascular arterial hypertension
Aslan, M., Basralı, F., Ülker, P., et al. (2023) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-023-02850-8 · Cited by 6
“A more recent study has also revealed that aurantiamide acetate significantly suppressed TNF-alpha production in LPS-induced acute lung injury in mice [19].”
BackgroundInfluentialChikopela, T., Goma, F. M., Kaluba, L., Mutale, W., Guure, C. B., Heimburger, D. C., & Koethe, J. R. (2021) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v22i1.1298 · Cited by 6
de Faria, A. P., Ritter, A. M. V., Catharina, A. S., de Souza, D. P., Naseri, E. P., Bértolo, M. B., Pioli, M. R., de Carvalho, C. C., Modolo, R., & Moreno, H. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20190514 · Cited by 24
Role of Nitric Oxide in Cardiovascular Alterations
Preiser, J. (2001) · Sepsis · doi:10.1023/a:1011498619555 · Cited by 6
Jiménez, A. M., Millás, I., Farré, J., García‐Méndez, A., Jiménez, P., Arriero, M., García-Colis, E., de Andrés, R., Gómez, J., Casado, S., et al. (2002) · Revista Española de Cardiología · doi:10.1016/s0300-8932(02)76778-x · Cited by 6
Localization of eNOS in the Olfactory Epithelium of the Rat
Endo, D., Yamamoto, Y., Yamaguchi‐Yamada, M., et al. (2010) · Journal of Veterinary Medical Science · doi:10.1292/jvms.10-0353 · Cited by 6
“In addition, eNOS mRNA is known to be stable and have a long half-life at 16–48 hr [40, 47].”
BackgroundVascular endothelial cell dysfunction in septic shock
Leclerc, J. B., Pu, Q., Wiel, É., et al. (2000) · Intensivmedizin und Notfallmedizin · doi:10.1007/s003900050302 · Cited by 6
Efecto de las estatinas más allá del colesterol
Álvarez, F. H., Duque, M. G., Vargas, J. C. O., Velázquez, B. S., Moreno, V. A., Villegas, E., Sánchez‐Reyes, L., & Fanghänel, G. (2006) · Revista de Endocrinología y Nutrición · Cited by 6
Endotheliale Funktionsstörung bei Patienten mit akutem Koronarsyndrom
Fichtlscherer, S., & Zeiher, A. M. (1999) · Herz · doi:10.1007/bf03044225 · Cited by 6
Physiology and Pathobiology of Microvascular Endothelium
Pober, J. S. (2008) · Comprehensive physiology · doi:10.1002/cphy.cp020402 · Cited by 4
Pawson, P., Reid, J. J., & Nolan, A. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703286 · Cited by 6
“It is not clear how endotoxin impairs endothelium-dependent relaxation, decreased stability of endothelial NOS mRNA (Yoshizumi et al., 1993) and altered receptor-e ector coupling have been proposed (DanielIssakani et al., 1989).”
BackgroundOverexpression of Plasma Membrane Annexin II In NO2-Exposed Pulmonary Artery Endothelial Cells
Li, Y. D., Patel, J. M., Zhang, J., et al. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00627-2 · Cited by 6
PHYSIOLOGY AND CELL BIOLOGY UPDATE Nitric Oxide in the Kidney: Synthesis, Localization, and Function
Bachmann, S., & Mundel, P. H. (1994) · Cited by 6
Pathophysiology of ischaemia-reperfusion injury
Carden, D. L., & Granger, D. N. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:3 · Cited by 5
Yu, L., Yang, W., Ling, R., Yu, Y., Dai, X. D., Sun, J., Zhang, J., & Zheng, X. (2025) · La radiologia medica · doi:10.1007/s11547-025-02063-2 · Cited by 5
“This dysfunction is one of the mechanisms that contribute to the development of INOCA by inhibiting the production of nitric oxide (NO), NO synthase (NOS), and prostacyclin (PGI2) [39–45].”
Repetitive ischemia increases myocardial dimethylarginine dimethylaminohydrolase 1 expression
Zhang, P., Fassett, J. T., Zhu, G., Li, J., Hu, X., Xu, X., Chen, Y., & Bache, R. J. (2017) · Vascular Medicine · doi:10.1177/1358863x16681215 · Cited by 5
Widlansky, M. E., & Malik, M. A. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_8 · Cited by 6
Nitric Oxide Expression in Cancer
Masini, E., Cianchi, F., Mastroianni, R., & Cuzzocrea, S. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1432-3_4 · Cited by 5
“alpha (TNF-α) down-regulates eNOS by enhancing the degradation of its messenger ribonucleic acid (mRNA) (Yoshizumi et al. 1993).”
BackgroundAndrzejczak, D., & Górska, D. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2013.08.006 · Cited by 5
“Thus, TNF-a could stimulate the angiotensinogenencoding gene [6] and limit the half-life of eNOS mRNA [51], whereas IL-1b has been shown to favor the development of atheromatous changes [27].”
BackgroundAdipocytokines and High Blood Pressure in Mexican Children
Gómez-Díaz, R. A., Rodríguez‐Morán, M., Mondragón-González, R., Wacher, N. H., & Guerrero‐Romero, F. (2019) · Endocrine Research · doi:10.1080/07435800.2019.1610771 · Cited by 5
Oxidants and Endothelial Dysfunction
Lund, A. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65250-9 · Cited by 6
Armando Rojas, R., González, D., Figueroa, H., Morales, M. A., & Romero, J. A. (2010) · Current Enzyme Inhibition · doi:10.2174/157340810790712050 · Cited by 5
“The major mechanism involved in down-regulation of eNOS expression seems to be due to an enhanced rate in mRNA degradation, as demonstrated for both tumor necrosis factor- and lipopolysaccharide [136, 137].”
BackgroundMateos‐Cáceres, P. J., Garcia-Cardoso, J. V., Lapuente, L., et al. (2006) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901461 · Cited by 5
Role of macrophage-derived nitric oxide in endotoxin lethality in mice
Parmely, M. J., Hao, S., Morrison, D. C., et al. (1995) · Journal of Endotoxin Research · doi:10.1177/096805199500200106 · Cited by 5
Shi, L., Du, X., Li, J., & Zhang, G. (2023) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s421193 · Cited by 5
Male versus female inflammatory response after brain death model followed by ex vivo lung perfusion
Ricardo‐da‐Silva, F. Y., Armstrong, R., Ramos, M. M. D. A., Vidal‐dos‐Santos, M., Correia, C. D. J., Ottens, P. J., Moreira, L. F. P., Leuvenink, H. G. D., & Breithaupt‐Faloppa, A. C. (2024) · Biology of Sex Differences · doi:10.1186/s13293-024-00581-8 · Cited by 4
“Cytokines such as TNF-α can reduces eNOS expression, by a post-transcriptional mechanism that destabilize the mRNA molecule [34], and can also independently or synergistically with IL-1β stimulate the expression of iNOS [35].”
BackgroundEffect of chronic periodontitis on the endothelial glycocalyx of rat penile corpus cavernosum
Xia, Y., Zeng, Y., & Jiang, R. (2024) · Andrology · doi:10.1111/andr.13765 · Cited by 4
Elevated levels of pro-thrombotic eNOS-negative platelets in COVID-19 patients
Asgari, A., Franczak, A., Herchen, A., Jickling, G. C., & Jurasz, P. (2024) · Thrombosis Research · doi:10.1016/j.thromres.2024.109178 · Cited by 4
Vascular Endothelial Cells as Immunological Targets in Atheroscleroisis
Fogal, B., & Pober, J. S. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0338-8_6 · Cited by 4
Insulin Resistance and Atherosclerosis. The Impact of Oxidative Stress on Endothelial Function
Fernández‐Real, J. M. (2008) · Revista Española de Cardiología · Cited by 4
TNF-α: A Benificial or Harmful Pathogenic Cytokine in Cardiovascular System
Dhiman, S., Kumar, I., Palia, P., Jamwal, S., & Kumar, P. (2021) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v11i1.4507 · Cited by 5
Kagota, S., Yamaguchi, Y., Nakamura, K., et al. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200407000-00006 · Cited by 4
“and protein expression in endothelial cells in in vitro experiments.(22,23) Furthermore, NO inhibits eNOS activity or its ex-”
BackgroundMatsubara, K., Matsubara, Y., & Ito, M. (2009) · Vascular Disease Prevention · doi:10.2174/1567270000906010163 · Cited by 6
Fujii, Y., Fujimura, N., Mikami, S., et al. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.05.095 · Cited by 4
Khonakdar-Tarsi, A. (2012) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb12.1577 · Cited by 4
“Yoshizumi et al demonstrated that TNF-ɑ extremely reduced the half-life of eNOS mRNA (Yoshizumi et al., 1993).”
BackgroundKardiovaskuläre Manifestationen bei Rheumatoider Arthritis
Moritz, F., Wagner, U. G., Distler, O., Seidel, W., Gay, S., & Häntzschel, H. (2005) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-005-0732-6 · Cited by 4
“Wie In-vitro-Untersuchungen zeigten, reduziert TNF die Expression von eNOS über eine Reduktion der eNOS-Gen-Promotoraktivität sowie der Stabilität eNOS-spezifischer Transkripte [19, 20].”
BackgroundPhysiology and Pathobiology of Microvascular Endothelium
Pober, J. S. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374530-9.00002-4 · Cited by 4
Matsubara, K., Matsubara, Y., & Ito, M. (2009) · Vascular Disease Prevention · doi:10.2174/1567270001006010163 · Cited by 4
Schwemmer, M., & Bassenge, E. (1999) · Nitric Oxide · doi:10.1006/niox.1999.0234 · Cited by 4
Cytokines Et Réactivité Vasculaire
Bernard, C., & Tedgui, A. (1994) · Réanimation Urgences · doi:10.1016/s1164-6756(05)80465-7 · Cited by 3
Zhang, W., Wang, Z., & Zhang, W. (2008) · Vascular Disease Prevention · doi:10.2174/1567270000401010019 · Cited by 4
“For example, an increased production of cytokines including TNF that is elevated in heart failure and can down-regulate NOS expression [30,31].”
BackgroundLocalization of nitric oxide synthase: alterations in disease
Buttery, L. D. K., & Polak, J. M. (1995) · Current Diagnostic Pathology · doi:10.1016/s0968-6053(00)80007-1 · Cited by 4
Xiao, J., Zhang, B., Su, Z., Liu, Y., Shelite, T. R., Chang, Q., Wang, P., Bukreyev, A. A., Soong, L., Jin, Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.04.282806 · Cited by 4
Immune Dysregulation Connecting Type 2 Diabetes and Cardiovascular Complications
Deck, K. S., Mora, C. J., Deng, S., Rogers, P., Rafferty, T. M., Palade, P., Mu, S., & Liu, Y. (2025) · Life · doi:10.3390/life15081241 · Cited by 5
“Subsequent mechanistic studies revealed that TNF α impaired the production of NO (nitro oxide) and increased superoxide generation through NADPH oxidase in several vascular beds [122,126,127].”
Widlansky, M. E., & Malik, M. A. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_8-1 · Cited by 3
Rho-Associated Kinase 2 Polymorphism of Vasospastic Angina in Korean Population
Park, C. S. (2012) · Korean Circulation Journal · doi:10.4070/kcj.2012.42.6.379 · Cited by 3
The effects of catechins on the cardiac mitochondria
Kopustinskienė, D. M., Bernatonienė, J., Jakštas, V., & Morkūnienė, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821562-3.00012-5 · Cited by 3
Ramírez, J. H. (2005) · Revista Estomatología · doi:10.25100/re.v13i2.5584 · Cited by 3
Nitric Oxide Inhibition in the Treatment of Septic Shock
Bone, H.-G., & Traber, D. L. (1996) · Critical Care Medicine · doi:10.1097/00003246-199608000-00025 · Cited by 3
Mondal, M., Sarkar, R. N., Chakroborty, A., et al. (2011) · Indian Journal of Rheumatology · doi:10.1016/s0973-3698(11)60059-9 · Cited by 3
The effect of tumour necrosis factor-α and insulin on equine digital blood vessel function in vitro
Menzies‐Gow, N. J., Wray, H., Bailey, S. R., Harris, P. A., & Elliott, J. (2014) · Inflammation Research · doi:10.1007/s00011-014-0736-2 · Cited by 3
“TNF-a (10 ng/ml) impaired NO production by bovine aortic endothelial cells in a timeand dose-dependent manner due to a reduction in eNOS expression [82–86].”
Carter, S. J., Bryan, D. R., Neumeier, W. H., Glasser, S. P., & Hunter, G. R. (2018) · International journal of exercise science · doi:10.70252/prws2257 · Cited by 3
“Previously, Yoshizumi and colleagues (31) showed that TNF-α interferes with normal vasodilation due to the inactivation of endothelial nitric oxide synthase.”
BackgroundNon solum… sed etiam: added cardiac benefits of TNFa blockade in rheumatoid arthritis
Raftery, G., & Armstrong, D. (2008) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.1177/1478271520083802004 · Cited by 3
Thiemermann, C. (1995) · Springer eBooks · doi:10.1007/978-3-642-79343-1_2 · Cited by 3
Fleming, I., & Busse, R. (1997) · Springer eBooks · doi:10.1007/978-1-4615-6039-5_8 · Cited by 3
The Renal Response to Sepsis and the Role of NOS Isoforms
Blantz, R. C., Satriano, J. A., & Schwartz, D. (1998) · Sepsis · doi:10.1023/a:1009732626174 · Cited by 3
Cytokine Regulation of Endothelial Cell Function
Mantovani, A., Allavena, P., Vecchi, A., Dejana, E., Sozzani, S., & Introna, M. (1998) · Springer eBooks · doi:10.1007/978-1-4899-0133-0_9 · Cited by 3
Rajasekaran, M. “., MONDAL, D., Agrawal, K. C., et al. (1998) · The Journal of Urology · doi:10.1097/00005392-199812010-00088 · Cited by 3
Vignozzi, L., Filippi, S., Comeglio, P., Cellai, I., Rastrelli, G., Morelli, A., Galli, A., Saad, F., Mannucci, E., Adorini, L., et al. (2014) · Endocrine Abstracts · doi:10.1530/endoabs.35.p696 · Cited by 3
Resistencia a la insulina y aterosclerosis. Impacto del estrés oxidativo en la función endotelial
Fernández‐Real, J. M. (2008) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(08)73554-4 · Cited by 2
Molecular Action of Herbal Medicine in Physiology of Erection and its Dysfunction
Rizal, D. M., & Septiyorini, N. (2022) · BIO Web of Conferences · doi:10.1051/bioconf/20224902002 · Cited by 2
Marbaniang, C., Sharan, R. N., & Kma, L. (2023) · Journal of Natural Remedies · doi:10.18311/jnr/2023/30648 · Cited by 2
Franzoni, L., da Motta, S. B., Carvalho, G., Costa, R. R., Ahner, M. M., Saffi, M., Pereira, A. A., Pereira, A. H., da Silveira, A. D., & Stein, R. (2024) · Current Cardiology Reviews · doi:10.2174/011573403x269909240320061952 · Cited by 2
Oxidants and Endothelial Dysfunction
Lund, A. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00071-1 · Cited by 2
Nzelu, D., Nicolaides, K. H., & Kametas, N. A. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16835 · Cited by 2
Pathobiology of Atherosclerosis
Tedgui, A., Bernard, C., & Mallat, Z. (1999) · Basic science for the cardiologist · doi:10.1007/978-0-585-38146-6_12 · Cited by 2
Doroszko, A., Andrzejak, R., & Szuba, A. (2008) · Cited by 2
Akyüz, A., Gür, D. Ö., Alpsoy, Ş., et al. (2019) · Biomarkers · doi:10.1080/1354750x.2019.1685004 · Cited by 2
“TNF- a is produced by monocytes and macrophages which promotes atherosclerosis and downregulates endothelial nitric oxide synthase (Yoshizumi et al. 1993).”
BackgroundRegulation of Nitric Oxide Synthase by Calmodulin
Hu, J., & Eldik, L. J. V. (1998) · Elsevier eBooks · doi:10.1016/b978-0-08-092636-0.50010-4 · Cited by 2
Ugovšek, S., Likozar, A. R., Finderle, S., et al. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9080281 · Cited by 2
“TNF-α-induced suppression of endothelial NO release is due to downregulation of mRNA for constitutive NO synthase [22].”
BackgroundThe Nitric Oxide Pathway in the Control of Myocardial Function: Role of Cytokines
Kelly, R. A., Longrois, D., Balligand, J., & Smith, T. W. (1995) · Springer eBooks · doi:10.1007/978-3-642-79343-1_14 · Cited by 2
Estrogen and nitric oxide in vasculature
Kauser, K. Z., & Rubanyi, G. M. (1999) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-199906000-00011 · Cited by 2
Evaluation of the Indomethacin-Nitroglycerin Interaction with Positron-Emission Tomography
Bednarcyzk, E. M., Furniss, S. M., Green, J. A., et al. (1997) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199712000-00005 · Cited by 2
The regulation of Osteopontin and soluble Neuropilin-1 in HIV- associated preeclampsia.
Naidoo, N. (2020) · ResearchSpace (University of KwaZulu-Natal) · Cited by 2
Nitric Oxide Synthases in Brain Function
Murphy, S. P., & Coughlan, T. C. (2006) · Springer eBooks · doi:10.1007/0-387-30395-2_11 · Cited by 2
Insulin Resistance and the Pathogenesis of Cardiovascular Disease
Ajjan, R., Kearney, M. T., & Grant, P. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-192-5_11 · Cited by 1
Effects of In Vitro Laminar Shear Stress as an Exercise Mimetic on Endothelial Cell Health
Brown, M. D., & Park, J. (2015) · Molecular and translational medicine · doi:10.1007/978-3-319-17076-3_7 · Cited by 1
Endothelial Dysfunction, Cytokines and Their Genetic Variations
Yücesoy, B. (2013) · CRC Press eBooks · doi:10.1201/b14907-6 · Cited by 1
Mechanistic and Methodological Considerations for the Imaging of Mental Stress Ischemia
Soufer, R., Burg, M. M., & Fernández, A. B. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05796-7.00058-8 · Cited by 1
Dietary salt and arterial stiffness
Edwards, D. G., & Farquhar, W. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91391-1.00053-4 · Cited by 1
Adiponectin, Diabetes, and the Cardiovascular System
Gasbarrino, K., Boutari, C., Filippaios, A., Gianopoulos, I., Daskalopoulou, S. S., & Mantzoros, C. S. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_8 · Cited by 1
Investigation the role of nitric oxide pathway in TNF-α induced HUVEC cells
Civelek, E., & Civelek, D. Ö. (2023) · Journal of Research in Pharmacy · doi:10.29228/jrp.441 · Cited by 1
Liu, J., & Pan, R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1495970 · Cited by 1
Voronkov, L. G., I.Shkurat, A. A., & Луцак, Е. А. (2008) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2008-4-2-38-40 · Cited by 1
Ovarian Nitric Oxide: A Local Regulator of Ovulation, Oocyte Maturation Luteal Function
OLSON, L. M. (1999) · Advances in developmental biochemistry · doi:10.1016/s1064-2722(08)60018-3 · Cited by 1
Quantitative measurement of endothelial constitutive nitric oxide synthase
Meurer, J., Blasko, E., Orme, A. E., et al. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)59205-3 · Cited by 1
Nitric Oxide and Cardiomyocyte Function
Balligand, J., & Cannon, P. (2000) · doi:10.1007/978-1-59259-002-5_10 · Cited by 1
Molekulare Mechanismen der Pr�eklampsie
Axt-Fliedner, R., Schroer, A., & Diedrich, K. (2004) · Der Gynäkologe · doi:10.1007/s00129-003-1480-9 · Cited by 1
Hedrich, O., Finley, J., Konstam, M. A., & Udelson, J. E. (2005) · Heart Failure Clinics · doi:10.1016/j.hfc.2004.12.002 · Cited by 1
Mechanisms of fructose-induced hypertension
Tran, T. X. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0067067 · Cited by 1
DIAGNOSTIC ASPECTS OF EXHALED NITRIC OXIDE IN CARDIOTHORACIC ANAESTHESIA
SZABÓ, A., Kövesi, T., GÁL, J., Royston, D., & Marczin, N. (2005) · doi:10.1142/9789812701954_0014 · Cited by 1
Amino Acid Transport in Disease
Ribeiro, A. C. M., & Brunini, T. M. C. (2003) · Springer eBooks · doi:10.1007/978-3-662-05181-8_27 · Cited by 1
Nitric Oxide Synthases in Brain Function
Murphy, S. P., & Coughlan, T. C. (2006) · Springer eBooks · doi:10.1007/978-0-387-30381-9_11 · Cited by 1
Examination of the periosteal microcirculation of long bones
Pócs, L. (2019) · doi:10.14232/phd.10176 · Cited by 1
Calderone, A. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-7960-5_14 · Cited by 1
Chen, Y. (2019) · Louisiana State University · doi:10.31390/gradschool_dissertations.4974 · Cited by 1
Immune Disorders Connecting Type2 Diabetes and Cardiovascular ComplicationsPreprint
Liu, Y. (2024) · Preprints.org · doi:10.20944/preprints202405.1951.v1
Protection of the Failing Heart
Podesser, B. K., Trescher, K., & Dietl, W. (2010) · Springer eBooks · doi:10.1007/978-3-211-85548-5_7 · Cited by 1
Metadata
- Authors
- Yoshizumi, M., Perrella, M. A., Burnett, J. C., & Lee, M. E.
- Affiliations
- Harvard University (US)
- Venue
- Circulation Research
- Published
- 1993-07
- Volume
- 73
- Issue
- 1
- Pages
- 205-209
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2145570729
- Cited by
- 771
- References
- 0
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 9 · 2023: 10 · 2022: 13 · 2021: 15 · 2020: 16 · 2019: 12 · 2018: 16 · 2017: 14 · 2016: 11 · 2015: 17 · 2014: 35 · 2013: 19 · 2012: 18
- FWCI
- 21.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- TNF-α, endothelial nitric oxide synthase, constitutive nitric oxide synthase, mRNA stability, mRNA degradation, human umbilical vein endothelial cells, atherosclerosis, cycloheximide, gene transcription
- MeSH terms
- Amino Acid Oxidoreductases, Base Sequence, Endothelium, Vascular, Half-Life, Humans, Molecular Sequence Data, RNA, Messenger, Transcription, Genetic, Tumor Necrosis Factor-alpha, Umbilical Veins, Down-Regulation, Polymerase Chain Reaction, Nitric Oxide Synthase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review